eversyn GmbH

eversyn GmbH

Biotechnologieforschung

Magdeburg, Saxony-Anhalt 727 Follower:innen

Making high-value glycans mainstream.

Info

eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Magdeburg, Saxony-Anhalt
Art
Privatunternehmen
Gegründet
2022
Spezialgebiete
Synthetic Glycobiotechnology, Glycobiotechnology, Biotechnology, Oligosaccharides, Nucleotide Sugars, In Vitro Glycoengineering, HMOs und activated sugars

Orte

  • Primär

    Pfaelzer Str. 25

    OvGU - Building 25

    Magdeburg, Saxony-Anhalt 39106, DE

    Wegbeschreibung

Beschäftigte von eversyn GmbH

Updates

Ähnliche Seiten

Finanzierung

eversyn GmbH Insgesamt 2 Finanzierungsrunden

Letzte Runde

Seed
Weitere Informationen auf Crunchbase